Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0001437749-25-019583 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-05 | 2025-06-03+ | ETON | BRYNJELSEN SEAN | Pres, CEO, Dir, 10% | S - Sale | $17.11 | -210.0K | 3.01M | -7% | -$3.59M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-04 | S | D | 70,000 | $17.00 | 2,943,513 | D | — | — | (F4) The shares were sold in multiple trades at prices ranging from $16.86 to $17.20. The price reported above reflects the weighted average sales price. (F6) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-06-05 | S | D | 70,000 | $16.81 | 2,873,513 | D | — | — | (F6) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F5) The shares were sold in multiple trades at prices ranging from $16.62 to $17.15. The price reported above reflects the weighted average sales price. |
| 3 | Common | Common Stock | 2025-06-03 | S | D | 8,655 | $18.38 | 3,013,913 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $18.15 to $18.85. The price reported above reflects the weighted average sales price. (F6) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-06-03 | S | D | 60,945 | $17.38 | 3,022,568 | D | — | — | (F6) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F1) The shares were sold in multiple trades at prices ranging from $17.00 to $17.88. The price reported above reflects the weighted average sales price. |
| 5 | Common | Common Stock | 2025-06-03 | S | D | 400 | $19.02 | 3,013,513 | D | — | — | (F3) The shares were sold in multiple trades at a price of $19.02. (F6) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |